Please log in to determine if you are eligible to purchase PT Programs.
INPT ANALYTE VOL FOR 1-5 LABS - QPA5
QPA5

It is well established that test ordering practices vary widely between health care providers even when adjusted for similar patient populations and conditions. These practices may involve test menu configuration, ordering protocols, or restriction policies such as use of laboratory formularies. Similarly, ordering practices can vary between facilities within the same health care system. A method to evaluate potential gaps in test utilization practices is to compare the adjusted volume of specific tests ordered between facilities both within the same health care system of laboratories and between different health care systems of laboratories. Differences detected in the quantity of specific tests performed can be useful for laboratories to identify potential issues in test-ordering practices. Ultimately, these gaps can affect the appropriateness of testing and optimal diagnosis and treatment for patients.

Objectives

The purpose of this study is to provide laboratory management participants with comparative benchmarks of various annual inpatient test analyte volumes. Test volumes will be standardized to optimize comparability amongst facilities. Findings can assist participants with their laboratory test ordering stewardship programs, and in meeting CAP Laboratory Accreditation checklist statements GEN.20316, QMS Indicators of Quality, to identify tests that are redundant, excessive, or noncontributory to good patient care, and evidence of compliance with DRA.10440 Effective Quality Management System, and DRA.10700 Director Responsibility–Consultations.* In addition, associations between test volumes and ordering practices in use by participants, such as menu design, reflex testing, decision support, standing orders, and restriction policies, will be evaluated.

Data Collection

Technologists will access a series of online, whole slide images to assess their ability to perform cell differentials on Wright-stained body fluids and to identify miscellaneous cells and inclusions in cytocentrifuged preparations using their own kit and result form. Participants will provide additional information about their competency assessment programs, continuing education, and professional background. Information will be collected from each site regarding their institution's minimum continuing education programs and requirements for their technologists who review body fluids, and relevant procedures and policies related to body fluid review assessment.

Information will be collected from each site regarding their institution's minimum continuing education requirements for their technologists in hematology and relevant procedures and policies related to body fluid slide review.

Performance Indicators

  • Standardized annual inpatient test volumes

Program Information

Your Reports – What to Expect:

Your institution’s standardized test volume results for each inpatient test studied in comparison to:

  • Similar participating institutions
  • Institutions within your integrated system, if applicable
  • If an institution reports a standardized inpatient test volume at higher or lower percentiles, the results can be seen on their Individual Report of Results for further examination.

    To meet your technical staff morphology and competency assessment requirements:

    • Result forms for 1–5 laboratories (QPA5)
    • Result forms for up to 10 laboratories (QPA10)
    • Multiple orders may be purchased to accommodate a higher quantity of sites.

    Participation in this study helps laboratories meet applicable requirements:

    • CLIA requirements: Collection of data and performance improvement, test appropriateness: §493.1200(b), §493.1200(c), §493.1239(c)
    • CAP Laboratory Accreditation Program Checklis statements: GEN.20316, QMS Indicators of Quality; DRA.10440 Effective Quality Management System (QMS): The laboratory director ensures an effective QMS for the laboratory; DRA.10700 Director Responsibility–Consultations: The laboratory director provides for intralaboratory consultations and clinical consultations regarding the ordering of appropriate tests and the medical significance of laboratory data.
    • Joint Commission Standards: LD.03.01.01 (EP 1, EP2), LD.03.02.01 (EP 1, EP 2) : leaders create and maintain a culture of safety and quality throughout the laboratory, collect and use data and information to guide decisions… in the performance of processes supporting safety and quality; LD.03.03.01 (EP1), LD.03.05.01; PI.01.01.01 (EP 2, EP 18): the laboratory collects data to determine whether tests it offers meet the needs of the clinical staff and the population served.

    Shipping Schedule

    • Shipment A: December 9, 2024

    For Comprehensive Collection of Tools, see Quality Management Tools.


     
    Select Q-PROBES and Q-TRACKS studies to support your quality improvement initiatives.
    Preanalytic
    Analytic
    Postanalytic
    Anatomic Pathology
    Clinical Pathology
    Turnaround Time
    Patient Safety
    Microbiology
    Transfusion Medicine
    Chemistry/ Hematology
    Customer Satisfaction
    Q-PROBES
    Laboratory Staffing Ratios QP251 (QPR-A)
    Assessment of Consistency of Body Fluid Morphologic
    Observations (QPB10/QPB25)
    Assessment of Consistency of Peripheral Blood
    Morphologic Observations (QPC10/QPC25)
    Assessment of Consistency of Gram Stain Morphologic Observations (QPD10/QPD25)
    Q-TRACKS
    Blood Culture Contamination (QT2)
    Laboratory Specimen Acceptability (QT3)
    In-Date Blood Product Wastage (QT4)
    Satisfaction with Outpatient Specimen Collection (QT7)
    Stat Test Turnaround Time Outliers (QT8)
    Critical Values Reporting (QT10)
    Corrected Results (QT16)
    Outpatient Order Entry Errors (QT17)

    *The CAP requires accredited laboratories to have a quality management plan that covers all areas of the laboratory and includes benchmarking key measures of laboratory performance (GEN.13806, GEN.20316, COM.04000). The Joint Commission requires accredited hospitals to regularly collect and analyze performance data (PI.01.01.01, PI.02.01.01). CLIA requires laboratories to monitor, assess, and correct problems identified in preanalytic, analytic, and postanalytic systems (§493.1249, §493.1289, §493.1299).






Customers Who Bought This Item Also Bought
BLOOD CULTURE CONTAMINATION
VIEW DETAILS >
LABORATORY SPECIMEN ACCEPTABILITY
VIEW DETAILS >
BLOOD PRODUCT WASTAGE
VIEW DETAILS >
OUTPATIENT SATISFACTION W/PHLEB SERVICE
VIEW DETAILS >
STAT TEST TURNAROUND TIME OUTLIERS
VIEW DETAILS >
ASSESS BODY FLUID MORPHOLOGY CONSISTENCY
VIEW DETAILS >
ASSESS BODY FLUID MORPHOLOGY CONSISTENCY
VIEW DETAILS >
ASSESS PERIPH BLD MORPHOLOGY CONSISTENCY
VIEW DETAILS >
ASSESS PERIPH BLD MORPHOLOGY CONSISTENCY
VIEW DETAILS >
ASSESS GRAM STAIN MORPHOLOGY CONSISTENCY
VIEW DETAILS >
ASSESS GRAM STAIN MORPHOLOGY CONSISTENCY
VIEW DETAILS >
CRITICAL VALUES REPORTING
VIEW DETAILS >
CORRECTED RESULTS
VIEW DETAILS >
OUTPATIENT ORDER ENTRY ERROR RATE
VIEW DETAILS >
INPT ANALYTE VOL FOR UP TO 10 LABS
VIEW DETAILS >